Single Dose Pharmacokinetic Study of CYCLOSET 0.8 mg Tablets Following Administration of a Weight-Adjusted Dose in Male and Female Children and Adolescent Type 2 Diabetes Mellitus Subjects VS-PEDS BA-2010-V4

Trial Profile

Single Dose Pharmacokinetic Study of CYCLOSET 0.8 mg Tablets Following Administration of a Weight-Adjusted Dose in Male and Female Children and Adolescent Type 2 Diabetes Mellitus Subjects VS-PEDS BA-2010-V4

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Sep 2016

At a glance

  • Drugs Bromocriptine (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors VeroScience
  • Most Recent Events

    • 26 Aug 2016 Status changed from recruiting to completed.
    • 23 Dec 2015 Planned End Date changed from 1 Dec 2016 to 1 Jun 2016 as per ClinicalTrials.gov record.
    • 23 Dec 2015 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2016 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top